Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current Approaches

Background and Aims: The initial management of deep vein thrombosis is starting to happen in general practice. New treatments are available to allow this shift, but guidance is variable. The aim of this study was to understand current choices used in general practice in the UK and to determine if th...

Full description

Bibliographic Details
Main Author: Pablo Millares Martin
Format: Article
Language:English
Published: European Medical Journal 2020-07-01
Series:European Medical Journal Hematology
Subjects:
Online Access:https://www.emjreviews.com/hematology/article/initial-anticoagulant-management-of-deep-vein-thrombosis-venous-thromboembolism-in-primary-care-review-of-current-approaches/
id doaj-08e148ce749d4649a37c7483f259c1eb
record_format Article
spelling doaj-08e148ce749d4649a37c7483f259c1eb2020-12-17T13:19:59ZengEuropean Medical JournalEuropean Medical Journal Hematology2053-66312020-07-01819399Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current ApproachesPablo Millares Martin0Whitehall Surgery, Wortley Beck Health Centre, Leeds, UKBackground and Aims: The initial management of deep vein thrombosis is starting to happen in general practice. New treatments are available to allow this shift, but guidance is variable. The aim of this study was to understand current choices used in general practice in the UK and to determine if there is a more efficient treatment, considering variability observed locally. Methods: A systematic literature review and freedom of information requests to England’s 198 clinical commissioning groups (CCG) were used to gather information on treatment options and current uses, respectively. Over 100 papers were assessed, and information from 177 CCG was obtained. Results: There is noninferiority between injectable low-molecular-weight heparin and novel oral anticoagulant treatments. Fifteen CCG offered variable, but also limited, options of treatment. Patient choice was not necessarily considered. Conclusion: There is variability in England on availability and choice of therapy for the initial management of deep vein thrombosis at present, which may also be the case elsewhere. The implementation of evidence-based guidelines should be carefully considered in all settings and countries.https://www.emjreviews.com/hematology/article/initial-anticoagulant-management-of-deep-vein-thrombosis-venous-thromboembolism-in-primary-care-review-of-current-approaches/deep vein thrombosis (dvt)managed carepatient-centred medical homepharmacologyprimary careproceduresvenous thromboembolism (vte)
collection DOAJ
language English
format Article
sources DOAJ
author Pablo Millares Martin
spellingShingle Pablo Millares Martin
Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current Approaches
European Medical Journal Hematology
deep vein thrombosis (dvt)
managed care
patient-centred medical home
pharmacology
primary care
procedures
venous thromboembolism (vte)
author_facet Pablo Millares Martin
author_sort Pablo Millares Martin
title Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current Approaches
title_short Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current Approaches
title_full Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current Approaches
title_fullStr Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current Approaches
title_full_unstemmed Initial Anticoagulant Management of Deep Vein Thrombosis/Venous Thromboembolism in Primary Care: Review of Current Approaches
title_sort initial anticoagulant management of deep vein thrombosis/venous thromboembolism in primary care: review of current approaches
publisher European Medical Journal
series European Medical Journal Hematology
issn 2053-6631
publishDate 2020-07-01
description Background and Aims: The initial management of deep vein thrombosis is starting to happen in general practice. New treatments are available to allow this shift, but guidance is variable. The aim of this study was to understand current choices used in general practice in the UK and to determine if there is a more efficient treatment, considering variability observed locally. Methods: A systematic literature review and freedom of information requests to England’s 198 clinical commissioning groups (CCG) were used to gather information on treatment options and current uses, respectively. Over 100 papers were assessed, and information from 177 CCG was obtained. Results: There is noninferiority between injectable low-molecular-weight heparin and novel oral anticoagulant treatments. Fifteen CCG offered variable, but also limited, options of treatment. Patient choice was not necessarily considered. Conclusion: There is variability in England on availability and choice of therapy for the initial management of deep vein thrombosis at present, which may also be the case elsewhere. The implementation of evidence-based guidelines should be carefully considered in all settings and countries.
topic deep vein thrombosis (dvt)
managed care
patient-centred medical home
pharmacology
primary care
procedures
venous thromboembolism (vte)
url https://www.emjreviews.com/hematology/article/initial-anticoagulant-management-of-deep-vein-thrombosis-venous-thromboembolism-in-primary-care-review-of-current-approaches/
work_keys_str_mv AT pablomillaresmartin initialanticoagulantmanagementofdeepveinthrombosisvenousthromboembolisminprimarycarereviewofcurrentapproaches
_version_ 1724379408414801920